These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16650366)
1. [Early effect of statins after myocardial infarction. A statin-induced pleiotropic effect?]. Martínez-González J; Badimon L Med Clin (Barc); 2006 Mar; 126(9):334-6. PubMed ID: 16650366 [No Abstract] [Full Text] [Related]
2. [Effect of statin treatment begun early after acute myocardial infarction on endothelial function in patients with normal levels of cholesterol. VAATOPE Study (VAlue of ATOrvastatin in Postinfarction Endothelium)]. Gómez-Doblas JJ; Jiménez-Navarro MF; García-Pinilla JM; Rodríguez-Bailón I; Robledo J; Cabrera F; Espinosa S; de Teresa E Med Clin (Barc); 2006 Mar; 126(9):325-8. PubMed ID: 16650363 [TBL] [Abstract][Full Text] [Related]
3. Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study. Osende JI; Ruiz-Ortega M; Blanco-Colio LM; Egido J Nephrol Dial Transplant; 2004 Mar; 19(3):528-31. PubMed ID: 14767002 [No Abstract] [Full Text] [Related]
4. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia. Gangaidzo IT Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346 [No Abstract] [Full Text] [Related]
5. Pleiotropic effects of statins and early benefit in the PROVE IT-TIMI-22 study. Poli A; Pujia A J Am Coll Cardiol; 2006 Aug; 48(4):852; author reply 852-3. PubMed ID: 16904573 [No Abstract] [Full Text] [Related]
6. Causal structures for evaluating statin class effects. Seeger JD Ann Pharmacother; 2002 Dec; 36(12):1961-5. PubMed ID: 12494951 [No Abstract] [Full Text] [Related]
7. Adjunctive interventions in myocardial infarction: the role of statin therapy. Jones PH; Farmer JA Curr Atheroscler Rep; 2008 Apr; 10(2):142-8. PubMed ID: 18417069 [TBL] [Abstract][Full Text] [Related]
17. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G; Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322 [TBL] [Abstract][Full Text] [Related]